《大行》大和降華虹(01347.HK)評級至「持有」 目標價上調至42元
大和發表報告指出,華虹半導體(01347.HK)第二季度業績表現喜憂參半。當中,收入符合市場預期,但得益於毛利率顯着改善,毛利大幅超出預期。淨利潤則較該行及市場預期分別低65%及38%。該行預計華虹將受益於2025年下半年的正面定價趨勢及需求回升,加之Fab 9廠房(12寸晶圓)產能擴張,進一步鞏固該行對其長期結構性前景的樂觀看法。
基於毛利率提升,該行下調華虹2025至2026年營運層面虧損預測,然而,近期股價上漲可能已反映這些正面催化因素,因此該行將12個月目標價從35港元上調至42港元,但將評級從「跑贏大市」下調至「持有」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.